Pharma spends $200 million on Turkey's anti-counterfeits scheme
11 February 2010
Elizabeth Sukkar
Please Login to read the full article.
11 February 2010
Elizabeth Sukkar
Research-based pharmaceutical firms in Turkey have spent some $200 million on equipment and production lines to meet the demands of the government's unique pack identification scheme which is designed to prevent counterfeit medicines entering the legal supply chain.
The national...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Council of Europe explains benefits of newly-launched eTACT anti-counterfeit system
- EU falsified meds directive published, but industry split over safety features
- New EU anti-counterfeiting rules: comprehensive but costly
- India set to mandate coding of all drugs to curb fakes
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
